These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32021185)

  • 21. Intracellular delivery of peptide nucleic acid and organic molecules using zeolite-L nanocrystals.
    Bertucci A; Lülf H; Septiadi D; Manicardi A; Corradini R; De Cola L
    Adv Healthc Mater; 2014 Nov; 3(11):1812-7. PubMed ID: 24789252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CuO nanoparticles incorporated in hierarchical MFI zeolite as highly active electrocatalyst for non-enzymatic glucose sensing.
    Dong J; Tian T; Ren L; Zhang Y; Xu J; Cheng X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():206-12. PubMed ID: 25499226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
    Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
    Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zeolite Nanoparticles Inhibit Aβ-Fibrinogen Interaction and Formation of a Consequent Abnormal Structural Clot.
    Derakhshankhah H; Hajipour MJ; Barzegari E; Lotfabadi A; Ferdousi M; Saboury AA; Ng EP; Raoufi M; Awala H; Mintova S; Dinarvand R; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30768-30779. PubMed ID: 27766857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zeolites in drug delivery: Progress, challenges and opportunities.
    Servatan M; Zarrintaj P; Mahmodi G; Kim SJ; Ganjali MR; Saeb MR; Mozafari M
    Drug Discov Today; 2020 Apr; 25(4):642-656. PubMed ID: 32062009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porous materials in catalysis: challenges for mesoporous materials.
    Perego C; Millini R
    Chem Soc Rev; 2013 May; 42(9):3956-76. PubMed ID: 23132427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
    Mosayebi J; Kiyasatfar M; Laurent S
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A data-guided approach for the evaluation of zeolites for hydrogen storage with the aid of molecular simulations.
    Manda T; Barasa GO; Louis H; Irfan A; Agumba JO; Lugasi SO; Pembere AMS
    J Mol Model; 2024 Jan; 30(2):43. PubMed ID: 38236500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zeolitic materials with hierarchical porous structures.
    Lopez-Orozco S; Inayat A; Schwab A; Selvam T; Schwieger W
    Adv Mater; 2011 Jun; 23(22-23):2602-15. PubMed ID: 21495091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rediscovery of the Importance of Inorganic Synthesis Parameters in the Search for New Zeolites.
    Shin J; Jo D; Hong SB
    Acc Chem Res; 2019 May; 52(5):1419-1427. PubMed ID: 31013053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of ROS-Responsive Substance P-Loaded Zeolite Imidazolate Framework-8 Nanoparticles into a Ca
    Zhu Y; Yao Z; Liu Y; Zhang W; Geng L; Ni T
    Int J Nanomedicine; 2020; 15():333-346. PubMed ID: 32021183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Bioimaging Applications of Mesoporous Silica Nanoparticles.
    Pratiwi FW; Kuo CW; Wu SH; Chen YP; Mou CY; Chen P
    Enzymes; 2018; 43():123-153. PubMed ID: 30244805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine for the treatment of Alzheimer's disease.
    Gregori M; Masserini M; Mancini S
    Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
    J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A compendium of potential energy maps of zeolites and molecular sieves.
    Keffer D; Gupta V; Kim D; Lenz E; Davis HT; McCormick AV
    J Mol Graph; 1996 Apr; 14(2):108-16, 100-4. PubMed ID: 8835777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.